ArticleCell death & disease2025

Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer.

Fernando Martín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.